盧美哌隆對(duì)甲苯磺酸鹽 Lumateperone Tosylate
盧美哌隆對(duì)甲苯磺酸鹽Lumateperone Tosylate
【化學(xué)名】 盧美哌隆對(duì)甲苯磺酸鹽Lumateperone Tosylate
【原研】百時(shí)美施貴寶
【上市時(shí)間】2019年12月20日
【用途】抑郁;精神分裂癥
【劑型/規(guī)格】口服膠囊劑,規(guī)格是EQ 42MG BASE; EQ 21MG BASE; EQ 10.5MG BASE。
盧美哌隆對(duì)甲苯磺酸鹽Lumateperone Tosylate
一、產(chǎn)品概述
Lumateperone是由百時(shí)美施貴寶研發(fā)的一種小分子藥物,是一種5-HT2A拮抗劑和DRD2拮抗劑。2019年12月20日,Lumateperone獲得美國(guó)食品藥品管理局FDA批準(zhǔn),由Intra-Cellular Therapies Inc銷(xiāo)售,商品名為Caplyta?。
二、主要產(chǎn)品
Description | Structural Formula | CAS No. | Category |
Lumateperone Tosylate | 1187020-80-9 | API | |
4aS,9bR)-6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (S)-2-Hydroxy-2-phenylacetate | 1059630-13-5 | intermediates | |
(6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline dihydrochloride | 2339905-28-9 | intermediates | |
4-chloro-1-(4-fluorophenyl)butan-1-one | 41167-07-1 or 3874-54-2 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.